Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nutritional High International Inc. Ordinary Shares SPLID

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
High Fusion Inc is engaged in the manufacturing, processing, and distribution of infused edible products. The company's operating and geographical segments include Palo Verde; Pasa Verde; Oregon; Colorado; Nevada and Washington. It generates maximum revenue from the Palo Verde segment.


OTCPK:SPLID - Post by User

Nutritional High International Inc. Ordinary Shares > News!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(47)
•••
Comment by Seagrindon May 30, 2018 8:30am
115 Views
Post# 28097816

RE:News!

RE:News!This is very strong news. Manufacturing and marketing of CBC and THC products in the two biggest and best markets in the world right now. And infusing cannabis with pterostilbene to improve bioavailability and marketing as a "cannabis energy" product, and with sales and distribution in Q3!!! That is awesome. Yup, good news indeed.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities